Patient info Open main menu

WILKO TICKLY COUGH 0.75G/5ML ORAL SOLUTION,BELLS CHILDRENS COUGH SYRUP BLACKCURRANT FLAVOUR,ASDA CHILDRENS DRY COUGH SYRUP GLYCERIN BLACKCURRANT FLAVOUR,HILLS BALSAM CHILDRENS DRY TICKLY COUGH 0.75G/5ML ORAL SOLUTION,ESSENTIAL WAITROSE CHILDRENS DRY - summary of medicine characteristics

Dostupné balení:

Summary of medicine characteristics - WILKO TICKLY COUGH 0.75G/5ML ORAL SOLUTION,BELLS CHILDRENS COUGH SYRUP BLACKCURRANT FLAVOUR,ASDA CHILDRENS DRY COUGH SYRUP GLYCERIN BLACKCURRANT FLAVOUR,HILLS BALSAM CHILDRENS DRY TICKLY COUGH 0.75G/5ML ORAL SOLUTION,ESSENTIAL WAITROSE CHILDRENS DRY

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 5ml contains: Glycerol                       ­0.75 gm

3 PHARMACEUTICAL FORM

Oral Solution

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

For the symptomatic relief of tickly coughs and sore throats.

4.2. Posology and method of administration

Adults the Elderly and children over 12 years: 5 to 10ml

Children 6 to 12 years: 5ml

Children 1 to 5 years: 2.5ml

Sip and swallow slowly three or four times a day.

4.3. Contraindications

Hypersensitivity to any of the constituents. Glucose malabsorption syndrome. Glucose intolerance due to sucrase or isomaltase deficiency.

4.4. Special warnings and precautions for use

Keep out of the sight and reach of children.

Shake bottle before use.

Care should be taken in patients with diabetes mellitus.

4.5. Interactions with other medicinal products and other forms of interaction

Citric acid may interact with potassium tartrate, carbonates and bicarbonates which , therefore, should not be administered at the same time.

4.6. Pregnancy and lactation

No data are available.

4.7. Effects on ability to drive and use machines

None.

4.8 Undesirable effects

None Known

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9. Overdose

There is no evidence that overdose is harmful.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Glycerin is a demulcent and humectant and soothes the throat.

5.2. Pharmaco­kinetic Properties

Pharmacokinetically glycerin when present in a dosage form such as a syrup will exert its desired action locally on the oro-pharynx.

5.3. Preclinical Safety Data

No relevant information additional to that already contained elsewhere in the SPC.

PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Sucrose

Liquid Glucose

Citric Acid Anhydrous BP

Blackcurrant Flavour

Anthocyanin

Purified Water

6.2. Incompatibilities

None.

6.3. Shelf Life

36 months in unopened bottle.

6.4. Special Precautions for Storage

6.4. Special Precautions for Storage

Do not store at a temperature exceeding 25oC. Store in the original container.

6.5 Nature and contents of container

Bottle: White flint or Amber (Type III) glass

Closures: Polypropylene Child resistant closure (CRC) fitted with low density polyethylene EPE/AL/PET liner

OR

Roll on pilfer proof (ROPP) screw cap fitted with low density polyethylene EPE/AL/PET liner

Size: 100 ml, 125 ml, 150 ml, 200 ml.

Not all pack sizes may be marketed

30 ml CE marked polypropylene measuring cup with 2.5 ml, 3.3 ml 4 ml, 5 ml, 7.5 ml, 10 ml, 15 ml, 20 ml and 25 ml graduations.

(May not be included in all marketed products)

6.6. Instruction for Use, Handling and Disposal

None.

MARKETING AUTHORISATION HOLDER

Bell, Sons & Co.

Gifford House

Slaidburn Crescent

Southport

Merseyside

PR9 9AL

8 MARKETING AUTHORISATION NUMBER(S)

PL 03105/0066

9 DATE OF FIRST AUTHORISATION/RE­NEWAL OF THE AUTHORISATION

29/05/2008